Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02337829
Title ACP-196 in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Acerta Pharma BV
Indications

chronic lymphocytic leukemia/small lymphocytic lymphoma

Therapies

Acalabrutinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Bethesda Maryland 20892 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field